Stay Curious. Stay Connected.
MailNewsletters♡Donate Now
Sign up
*Password must be at least 8 characters and contain one uppercase letter, one lowercase letter, one number and one symbol.
Already have an account?
By submitting, you consent that you are at least 18 years of age and to receive information about MPR's or APMG entities' programs and offerings. The personally identifying information you provide will not be sold, shared, or used for purposes other than to communicate with you about MPR, APMG entities, and its sponsors. You may opt-out at any time clicking the unsubscribe link at the bottom of any email communication. View our Privacy Policy.
Sign in to your profile
Forgot Password?
New to MPR News?
Welcome back
to news
for you
Reset Password

Enter the username on file and we'll send you a code to reset your password.

Still require assistance or not sure what your User Name is?
Welcome back
to news
for you
Email Verification

A verification code has been emailed to

Still awaiting the code?
Martin Moylan

St. Jude Medical to settle suits over product linked to deaths

Go Deeper.

Create an account or log in to save stories.

Like this?

Thanks for liking this story! We have added it to a list of your favorite stories.

Medical-device maker St. Jude Medical expects to pay about $14.5 million to settle litigation over a discontinued product linked to 22 patient deaths.

The settlement involves Riata-brand wires that connect an implanted defibrillator to the heart. A defibrillator delivers an electric shock to jolt a stopped or erratically beating heart back to its normal rhythm.

St. Jude stopped selling the connectors in late 2010, amid reports wire was breaking through protective insulation, causing malfunctions. The defect can lead to inappropriate shock — or a failure to provide a life-saving jolt of electricity when a patient's heart stops.

"St. Jude Medical has entered into an agreement to settle a majority of our known U.S. lawsuits and claims related to Riata," company spokeswoman Candace Steele Flippin said. "We have resolved approximately 950 cases."

St. Jude admitted no liability and disputes that the wires were at fault.

The company said patient safety is its highest priority and it monitors the Riata leads that are still implanted in about 90,000 patients. The federal Food and Drug Administration doesn't recommend replacement of leads functioning normally.

In the litigation to date, less than one percent of claims involved patient deaths related to Riata, according to the company. That includes claims related to surgeries to remove the leads. St. Jude Medical contends those claims are not device related.